Race-specific type 1 diabetes risk of HLA-DR7 haplotypes

J. A. Noble, J. Johnson, J. A. Lane, A. M. Valdes

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The aim of this study was to test the hypothesis that closely related human leukocyte antigen (HLA) haplotypes containing the DRB1 *07:01 gene ['DR7' (DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g or DRB1 *07:01-DQA1 *03:01-DQB1 *02:01g) haplotypes] derived from European and African populations differ in their genetic susceptibility for type 1 diabetes (T1D) depending on the DQ-α molecule present. A combined total of 98 African American T1D patients from the Type 1 Diabetes Genetics Consortium and from Children's Hospital and Research Center Oakland were genotyped for the HLA class II loci DRB1, DQA1, and DQB1. DNA samples extracted from newborn blood spot cards from African Americans born in California (n = 947) were used as a population-based control group. Among African American cases, the European-derived DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g haplotype was protective for T1D risk (odds ratio (OR) = 0.34; 95% confidence interval (CI) 0.14-0.78; P < 0.011), but the African-derived DRB1 *07:01-DQA1 *03:01-DQB1 *02:01g haplotype increased T1D risk (OR = 3.96; 95% CI 1.94-8.08; P < 5.5E-05). The effect of DRB1 *07:01-DQB1 *02:01g on T1D susceptibility depends on the DQA1 allele. DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g is protective for T1D; however, the presence of DQA1 *03:01 on the DRB1 *07:01-DQB1 *02:01g haplotype not only renders the DR7 haplotype not protective but also creates a haplotype with significant T1D risk. These data underscore the importance of assessing genetic effects within ethnic context.

Original languageEnglish (US)
Pages (from-to)348-351
Number of pages4
JournalTissue Antigens
Volume78
Issue number5
DOIs
StatePublished - Nov 2011
Externally publishedYes

Fingerprint

HLA Antigens
Type 1 Diabetes Mellitus
Haplotypes
Odds Ratio
African Americans
Confidence Intervals
Population Control
Genetic Predisposition to Disease
Alleles
Newborn Infant
Control Groups
DNA
Research
Population
Genes

Keywords

  • African American
  • Genetic risk
  • HLA class II
  • HLA DR7
  • Type 1 diabetes

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Genetics

Cite this

Noble, J. A., Johnson, J., Lane, J. A., & Valdes, A. M. (2011). Race-specific type 1 diabetes risk of HLA-DR7 haplotypes. Tissue Antigens, 78(5), 348-351. https://doi.org/10.1111/j.1399-0039.2011.01772.x

Race-specific type 1 diabetes risk of HLA-DR7 haplotypes. / Noble, J. A.; Johnson, J.; Lane, J. A.; Valdes, A. M.

In: Tissue Antigens, Vol. 78, No. 5, 11.2011, p. 348-351.

Research output: Contribution to journalArticle

Noble, JA, Johnson, J, Lane, JA & Valdes, AM 2011, 'Race-specific type 1 diabetes risk of HLA-DR7 haplotypes', Tissue Antigens, vol. 78, no. 5, pp. 348-351. https://doi.org/10.1111/j.1399-0039.2011.01772.x
Noble, J. A. ; Johnson, J. ; Lane, J. A. ; Valdes, A. M. / Race-specific type 1 diabetes risk of HLA-DR7 haplotypes. In: Tissue Antigens. 2011 ; Vol. 78, No. 5. pp. 348-351.
@article{9e8764aeec52420d87d0bfae5307924e,
title = "Race-specific type 1 diabetes risk of HLA-DR7 haplotypes",
abstract = "The aim of this study was to test the hypothesis that closely related human leukocyte antigen (HLA) haplotypes containing the DRB1 *07:01 gene ['DR7' (DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g or DRB1 *07:01-DQA1 *03:01-DQB1 *02:01g) haplotypes] derived from European and African populations differ in their genetic susceptibility for type 1 diabetes (T1D) depending on the DQ-α molecule present. A combined total of 98 African American T1D patients from the Type 1 Diabetes Genetics Consortium and from Children's Hospital and Research Center Oakland were genotyped for the HLA class II loci DRB1, DQA1, and DQB1. DNA samples extracted from newborn blood spot cards from African Americans born in California (n = 947) were used as a population-based control group. Among African American cases, the European-derived DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g haplotype was protective for T1D risk (odds ratio (OR) = 0.34; 95{\%} confidence interval (CI) 0.14-0.78; P < 0.011), but the African-derived DRB1 *07:01-DQA1 *03:01-DQB1 *02:01g haplotype increased T1D risk (OR = 3.96; 95{\%} CI 1.94-8.08; P < 5.5E-05). The effect of DRB1 *07:01-DQB1 *02:01g on T1D susceptibility depends on the DQA1 allele. DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g is protective for T1D; however, the presence of DQA1 *03:01 on the DRB1 *07:01-DQB1 *02:01g haplotype not only renders the DR7 haplotype not protective but also creates a haplotype with significant T1D risk. These data underscore the importance of assessing genetic effects within ethnic context.",
keywords = "African American, Genetic risk, HLA class II, HLA DR7, Type 1 diabetes",
author = "Noble, {J. A.} and J. Johnson and Lane, {J. A.} and Valdes, {A. M.}",
year = "2011",
month = "11",
doi = "10.1111/j.1399-0039.2011.01772.x",
language = "English (US)",
volume = "78",
pages = "348--351",
journal = "HLA",
issn = "2059-2302",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Race-specific type 1 diabetes risk of HLA-DR7 haplotypes

AU - Noble, J. A.

AU - Johnson, J.

AU - Lane, J. A.

AU - Valdes, A. M.

PY - 2011/11

Y1 - 2011/11

N2 - The aim of this study was to test the hypothesis that closely related human leukocyte antigen (HLA) haplotypes containing the DRB1 *07:01 gene ['DR7' (DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g or DRB1 *07:01-DQA1 *03:01-DQB1 *02:01g) haplotypes] derived from European and African populations differ in their genetic susceptibility for type 1 diabetes (T1D) depending on the DQ-α molecule present. A combined total of 98 African American T1D patients from the Type 1 Diabetes Genetics Consortium and from Children's Hospital and Research Center Oakland were genotyped for the HLA class II loci DRB1, DQA1, and DQB1. DNA samples extracted from newborn blood spot cards from African Americans born in California (n = 947) were used as a population-based control group. Among African American cases, the European-derived DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g haplotype was protective for T1D risk (odds ratio (OR) = 0.34; 95% confidence interval (CI) 0.14-0.78; P < 0.011), but the African-derived DRB1 *07:01-DQA1 *03:01-DQB1 *02:01g haplotype increased T1D risk (OR = 3.96; 95% CI 1.94-8.08; P < 5.5E-05). The effect of DRB1 *07:01-DQB1 *02:01g on T1D susceptibility depends on the DQA1 allele. DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g is protective for T1D; however, the presence of DQA1 *03:01 on the DRB1 *07:01-DQB1 *02:01g haplotype not only renders the DR7 haplotype not protective but also creates a haplotype with significant T1D risk. These data underscore the importance of assessing genetic effects within ethnic context.

AB - The aim of this study was to test the hypothesis that closely related human leukocyte antigen (HLA) haplotypes containing the DRB1 *07:01 gene ['DR7' (DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g or DRB1 *07:01-DQA1 *03:01-DQB1 *02:01g) haplotypes] derived from European and African populations differ in their genetic susceptibility for type 1 diabetes (T1D) depending on the DQ-α molecule present. A combined total of 98 African American T1D patients from the Type 1 Diabetes Genetics Consortium and from Children's Hospital and Research Center Oakland were genotyped for the HLA class II loci DRB1, DQA1, and DQB1. DNA samples extracted from newborn blood spot cards from African Americans born in California (n = 947) were used as a population-based control group. Among African American cases, the European-derived DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g haplotype was protective for T1D risk (odds ratio (OR) = 0.34; 95% confidence interval (CI) 0.14-0.78; P < 0.011), but the African-derived DRB1 *07:01-DQA1 *03:01-DQB1 *02:01g haplotype increased T1D risk (OR = 3.96; 95% CI 1.94-8.08; P < 5.5E-05). The effect of DRB1 *07:01-DQB1 *02:01g on T1D susceptibility depends on the DQA1 allele. DRB1 *07:01-DQA1 *02:01-DQB1 *02:01g is protective for T1D; however, the presence of DQA1 *03:01 on the DRB1 *07:01-DQB1 *02:01g haplotype not only renders the DR7 haplotype not protective but also creates a haplotype with significant T1D risk. These data underscore the importance of assessing genetic effects within ethnic context.

KW - African American

KW - Genetic risk

KW - HLA class II

KW - HLA DR7

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=80053930830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053930830&partnerID=8YFLogxK

U2 - 10.1111/j.1399-0039.2011.01772.x

DO - 10.1111/j.1399-0039.2011.01772.x

M3 - Article

VL - 78

SP - 348

EP - 351

JO - HLA

JF - HLA

SN - 2059-2302

IS - 5

ER -